KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Cost of Revenue (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Cost of Revenue for 16 consecutive years, with $3.2 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Cost of Revenue fell 13.23% year-over-year to $3.2 billion, compared with a TTM value of $12.7 billion through Dec 2024, down 6.18%, and an annual FY2025 reading of $13.4 billion, up 5.93% over the prior year.
  • Cost of Revenue was $3.2 billion for Q4 2024 at Thermo Fisher Scientific, up from $3.2 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $6.9 billion in Q4 2021 and bottomed at -$2.9 billion in Q4 2020.
  • Average Cost of Revenue over 5 years is $2.9 billion, with a median of $3.2 billion recorded in 2023.
  • The sharpest move saw Cost of Revenue tumbled 98.91% in 2021, then surged 26776.92% in 2022.
  • Year by year, Cost of Revenue stood at -$2.9 billion in 2020, then surged by 335.97% to $6.9 billion in 2021, then tumbled by 46.65% to $3.7 billion in 2022, then increased by 1.39% to $3.7 billion in 2023, then decreased by 13.23% to $3.2 billion in 2024.
  • Business Quant data shows Cost of Revenue for TMO at $3.2 billion in Q4 2024, $3.2 billion in Q3 2024, and $3.1 billion in Q2 2024.